Compare CLPT & CCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLPT | CCAP |
|---|---|---|
| Founded | 1998 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 494.6M | 492.4M |
| IPO Year | 2009 | N/A |
| Metric | CLPT | CCAP |
|---|---|---|
| Price | $10.74 | $12.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $21.50 | $16.33 |
| AVG Volume (30 Days) | ★ 948.0K | 177.4K |
| Earning Date | 04-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.11% |
| EPS Growth | ★ 22.22 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $31,390,000.00 | N/A |
| Revenue This Year | $18.93 | N/A |
| Revenue Next Year | $51.64 | N/A |
| P/E Ratio | ★ N/A | $14.18 |
| Revenue Growth | ★ 31.04 | N/A |
| 52 Week Low | $8.63 | $12.56 |
| 52 Week High | $30.10 | $17.97 |
| Indicator | CLPT | CCAP |
|---|---|---|
| Relative Strength Index (RSI) | 41.50 | 37.77 |
| Support Level | $10.57 | $12.56 |
| Resistance Level | $11.69 | $14.70 |
| Average True Range (ATR) | 1.01 | 0.42 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 31.38 | 23.04 |
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.